Neurodegenerative disease: Tau immunotherapy targets transcellular propagation.
Monica Hoyos
MH
Flight
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism*; D003072:Cognition Disorders / Q000188:drug therapy*; D006801:Humans; D024801:Tauopathies / Q000188:drug therapy*; D016875:tau Proteins / Q000037:antagonists & inhibitors* / Q000276:immunology*
D000911:Antibodies, Monoclonal; D016875:tau Proteins